187 related articles for article (PubMed ID: 10408854)
1. Alteration of p16 and p15 genes in human uterine tumours.
Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
[TBL] [Abstract][Full Text] [Related]
2. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
[TBL] [Abstract][Full Text] [Related]
3. Alteration of p16 and p15 genes in common epithelial ovarian tumors.
Fujita M; Enomoto T; Haba T; Nakashima R; Sasaki M; Yoshino K; Wada H; Buzard GS; Matsuzaki N; Wakasa K; Murata Y
Int J Cancer; 1997 Apr; 74(2):148-55. PubMed ID: 9133447
[TBL] [Abstract][Full Text] [Related]
4. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
6. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
8. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas.
Zhao Y; Zhang S; Fu B; Xiao C
Cancer Genet Cytogenet; 1999 Jul; 112(1):26-33. PubMed ID: 10432931
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
[TBL] [Abstract][Full Text] [Related]
13. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
[TBL] [Abstract][Full Text] [Related]
14. Frequent hypermethylation of p16 and p15 genes in multiple myeloma.
Ng MH; Chung YF; Lo KW; Wickham NW; Lee JC; Huang DP
Blood; 1997 Apr; 89(7):2500-6. PubMed ID: 9116295
[TBL] [Abstract][Full Text] [Related]
15. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
17. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines.
Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637
[TBL] [Abstract][Full Text] [Related]
18. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL
Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
20. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK
Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
